Nova Allegro UACR Assay, Nova Allegro Analyzer
Alkaline Picrate, Colorimetry, Creatinine. 510(k) K252206, from Nova Biomedical Corporation (Walham, MA). Product code CGX, class 2.
As of Nov 20, 2026, K252206 is an FDA 510(k) held by Nova Biomedical Corporation, substantially equivalent on Jan 9, 2026 after 179 days, with no recalls tied to it in FDA's recall database.
- Review time: 179 days
- Recalls: 0
The Nova Allegro urine albumin creatinine ratio (UACR) assay is intended for the quantitative determination of albumin, creatinine, and the albumin/creatinine ratio (UACR) in human urine. The measurement of urine albumin, creatinine, and albumin/creatinine ratio aids in the early diagnosis of nephropathy.
- Nova Allegro UACR Assay, Nova Allegro AnalyzerK221813 · Nova Biomedical Corporation · Nov 19, 2024
- Tru Kidney Health Test Panel; Tru AnalyzerK251058 · Truvian Health · Nov 26, 2025
- Atellica® CH Creatinine_3 (Crea3)K242685 · Siemens Healthcare Diagnostics, Inc. · Dec 4, 2024
- Creatinine2K210452 · Abbott Ireland Diagnostics Division · Mar 22, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Dual Track
- Received
- Jul 14, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files